National Integrated Care Conference for Cardiometabolic Medicines Optimisation

The first PM Cardiometabolic Conference will be hosted virtually on 23rd March 2022.

This event will be of interest to pharmacists and pharmacy technicians of all levels working in the fields of cardiovascular and diabetes medicines.

Agenda and further details will be uploaded once confirmed.

This event is sponsored by the following companies who have had no input into the design or content of the webinar except from their own sessions.

Bayer - Headline Sponsor

This meeting has been sponsored by Bayer and they will deliver a sponsored session titled ‘A practical approach to holistic management of patients with NVAF’ that may contain promotional content. Aside from their sponsored session, Bayer have had no influence on the wider selection of speakers, content or agenda development. Adverse Event and Prescribing Information is available at the end of the presentation.  (February 2022. RP-XAR-GB-3969).

AstraZeneca - Silver Sponsor

AstraZeneca has provided a sponsorship grant towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers except for the AstraZeneca sponsored symposia presentation.

Pfizer - Silver Sponsor

This promotional session is organised and funded by Pfizer Ltd on behalf of the BMS/Pfizer Alliance. Adverse event reporting and prescribing information are available at the end of the presentation.

PP-ELI-GBR-10148 March 2022

Daiichi-Sankyo - Silver Sponsor